Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The essential fatty acids (EFAs) metabolic pathway is a series of biochemical reactions that convert dietary omega-3 (α-linolenic acid, ALA) and omega-6 (linoleic acid, LA) fatty acids into longer-chain polyunsaturated fatty acids (PUFAs) like arachidonic acid (AA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). These PUFAs and their bioactive metabolites, such as eicosanoids and endocannabinoids, are crucial for cellular function, inflammation regulation, and overall health. Humans cannot synthesize EFAs de novo and must obtain them from their diet.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Essential Fatty Acids Metabolic Pathway (EFA Pathway).